AstraZeneca
has demonstrated efficacy across multiple cancer types | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
10 of 43
Related slides by other companies
Genelux
Investor Presentation
October 2023
diversified designs and indications exploit competitive advantages bene | Genelux
Genelux
Investor Presentation
December 2023
program builds on completed trials to exploit competitive advantages estimated billion dollar plus annual commercial opportunity us | Genelux
Genelux
Investor Presentation
July 2023
diversified designs and indications exploit competitive advantages bene | Genelux
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights